These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 37930837)

  • 21. Bioinformatics in drug development and assessment.
    Wishart DS
    Drug Metab Rev; 2005; 37(2):279-310. PubMed ID: 15931766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of drug-metabolizing enzymes by local and systemic liver injuries.
    Guo Y; Hu B; Xie Y; Billiar TR; Sperry JL; Huang M; Xie W
    Expert Opin Drug Metab Toxicol; 2016; 12(3):245-51. PubMed ID: 26751558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases.
    Caspi R; Billington R; Ferrer L; Foerster H; Fulcher CA; Keseler IM; Kothari A; Krummenacker M; Latendresse M; Mueller LA; Ong Q; Paley S; Subhraveti P; Weaver DS; Karp PD
    Nucleic Acids Res; 2016 Jan; 44(D1):D471-80. PubMed ID: 26527732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DrugBank 3.0: a comprehensive resource for 'omics' research on drugs.
    Knox C; Law V; Jewison T; Liu P; Ly S; Frolkis A; Pon A; Banco K; Mak C; Neveu V; Djoumbou Y; Eisner R; Guo AC; Wishart DS
    Nucleic Acids Res; 2011 Jan; 39(Database issue):D1035-41. PubMed ID: 21059682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MuteinDB: the mutein database linking substrates, products and enzymatic reactions directly with genetic variants of enzymes.
    Braun A; Halwachs B; Geier M; Weinhandl K; Guggemos M; Marienhagen J; Ruff AJ; Schwaneberg U; Rabin V; Torres Pazmiño DE; Thallinger GG; Glieder A
    Database (Oxford); 2012; 2012():bas028. PubMed ID: 22730453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FragmentStore--a comprehensive database of fragments linking metabolites, toxic molecules and drugs.
    Ahmed J; Worth CL; Thaben P; Matzig C; Blasse C; Dunkel M; Preissner R
    Nucleic Acids Res; 2011 Jan; 39(Database issue):D1049-54. PubMed ID: 20965964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physiochemical property space distribution among human metabolites, drugs and toxins.
    Khanna V; Ranganathan S
    BMC Bioinformatics; 2009 Dec; 10 Suppl 15(Suppl 15):S10. PubMed ID: 19958509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in Toxicological and Pharmacological Responses Mediated by Polymorphic Cytochromes P450 and Related Drug-Metabolizing Enzymes.
    Yamazaki H
    Chem Res Toxicol; 2017 Jan; 30(1):53-60. PubMed ID: 27750412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of drug-metabolizing enzymes: mechanisms and consequences.
    Okey AB; Roberts EA; Harper PA; Denison MS
    Clin Biochem; 1986 Apr; 19(2):132-41. PubMed ID: 3518989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of biotransformation in drug-induced toxicity: influence of intra- and inter-species differences in drug metabolism.
    Baillie TA; Rettie AE
    Drug Metab Pharmacokinet; 2011; 26(1):15-29. PubMed ID: 20978360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer.
    Nebert DW; McKinnon RA; Puga A
    DNA Cell Biol; 1996 Apr; 15(4):273-80. PubMed ID: 8639263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
    Singh SS
    Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aliphatic and aromatic oxidations, epoxidation and S-oxidation of prodrugs that yield active drug metabolites.
    Tekes K; Kalász H; Hasan MY; Adeghate E; Darvas F; Ram N; Adem A
    Curr Med Chem; 2011; 18(32):4885-900. PubMed ID: 22050741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adaptive increases in drug-metabolizing enzymes induced by phenobarbital and other drugs.
    CONNEY AH; DAVISON C; GASTEL R; BURNS JJ
    J Pharmacol Exp Ther; 1960 Sep; 130():1-8. PubMed ID: 13811549
    [No Abstract]   [Full Text] [Related]  

  • 35. Review of MARCH-INSIDE & complex networks prediction of drugs: ADMET, anti-parasite activity, metabolizing enzymes and cardiotoxicity proteome biomarkers.
    González-Díaz H; Duardo-Sanchez A; Ubeira FM; Prado-Prado F; Pérez-Montoto LG; Concu R; Podda G; Shen B
    Curr Drug Metab; 2010 May; 11(4):379-406. PubMed ID: 20446904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DITOP: drug-induced toxicity related protein database.
    Zhang JX; Huang WJ; Zeng JH; Huang WH; Wang Y; Zhao R; Han BC; Liu QF; Chen YZ; Ji ZL
    Bioinformatics; 2007 Jul; 23(13):1710-2. PubMed ID: 17463030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug metabolism and toxicity during hypoxia.
    Jones DP; Aw TY; Shan XQ
    Drug Metab Rev; 1989; 20(2-4):247-60. PubMed ID: 2680383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TheMarker: a comprehensive database of therapeutic biomarkers.
    Zhang Y; Zhou Y; Zhou Y; Yu X; Shen X; Hong Y; Zhang Y; Wang S; Mou M; Zhang J; Tao L; Gao J; Qiu Y; Chen Y; Zhu F
    Nucleic Acids Res; 2024 Jan; 52(D1):D1450-D1464. PubMed ID: 37850638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive assessment of ADMET risks in drug discovery.
    Wang J
    Curr Pharm Des; 2009; 15(19):2195-219. PubMed ID: 19601823
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.